Concepedia

Lalji K. Gediya

LK

22

Publications

1.4K

Citations

18

H-Index

1999

Active since

Affiliations

University of Maryland, Baltimore(Current)

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Thomas Jefferson University

U-M Rogel Cancer Center

Ankara University

Lalji K. Gediya is an author at University of Maryland, Baltimore specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1999–2019

22

Publications

22

Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens:  Synthesis, in Vitro Biological Activity, Pharmacokinetics, and Antitumor Activity in the LAPC4 Human Prostate Cancer Xenograft Model

Venkatesh Handratta, Tadas S. Vasaitis, Vincent C.O. Njar et al. · Journal of Medicinal Chemistry · 2005 · 246 citations · Full text

Promise and challenges in drug discovery and development of hybrid anticancer drugs

Lalji K. Gediya, Vincent C.O. Njar · Expert Opinion on Drug Discovery · 2009 · 216 citations

Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1<i>H</i>-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer

Tadas S. Vasaitis, Aashvini Belosay, Adam Schayowitz et al. · Molecular Cancer Therapeutics · 2008 · 134 citations · Full text

Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya et al. · Journal of Medicinal Chemistry · 2013 · 103 citations · Full text

, , +22

A New Simple and High-Yield Synthesis of Suberoylanilide Hydroxamic Acid and Its Inhibitory Effect Alone or in Combination with Retinoids on Proliferation of Human Prostate Cancer Cells

Lalji K. Gediya, Pankaj Chopra, Puranik Purushottamachar et al. · Journal of Medicinal Chemistry · 2005 · 98 citations

Rows per page

1–5 of 22